55 articles
ICIS Europe highlights acrylate ester duties, bullish ethanol markets, and BASF-Evonik M&A talks alongside fertilizer shortfalls threatening food security. Key petrochemical trends include polyethylen
BASF raised its full-year EBITDA forecast to €7.4–7.8 billion following strong core performance, with Q3 sales surging 14.2% due to higher prices. The company confirmed ongoing restructuring and descr
BASF CEO Markus Kamieth stated acquiring Evonik is logically sound but warned against overpaying amid a renewed €24/share offer. The deal aims to merge BASF's feedstock capabilities with Evonik's spec
BASF CEO Markus Kamieth expressed willingness to negotiate a merger with Evonik to boost global competitiveness and supply chain efficiency. The proposal emphasizes job preservation and operational sy
Evonik has partnered with Toho Kasei and San-yo Chemical to establish a polyurethane foam recycling system in Japan using hydrolysis technology. The project converts waste foam into high-quality regen
BASF has indicated it will maintain Evonik's German employment guarantees until 2032 in any potential takeover agreement. This commitment addresses political and union concerns following Evonik's reje
ICIS Europe's weekly roundup covers rising polyethylene margins, Evonik rejecting BASF's €10.3 billion takeover bid, and logistical disruptions from low Rhine water levels affecting chemical trade.
The CW75 index fell 0.98% for the week ending Sept. 29, outperforming broader markets, while Evonik shares surged following reports of a €10.3 billion acquisition bid from BASF.
The RAG Foundation confirmed it could sell its entire 43% stake in Evonik, following competitor BASF's recent takeover interest. Such a divestment requires board approval and would significantly impac
Experts discuss how a potential BASF and Evonik merger could establish an integrated regional leader to compete in the oversupplied global chemical market. Consolidation is highlighted as vital for Eu
Evonik executives report Mexico's chemical sector is recovering from trade-induced slowdowns with sustained investment despite pending USMCA renewals. While record exports signal resilience, access to
Evonik rejected a takeover offer from BASF valued at roughly €22.15 per share, sources say, calling the price too low. BASF had proposed the acquisition earlier in the week.
Evonik rejected BASF's €10.3 billion takeover bid, stating it was too low for formal negotiations or due diligence, per Financial Times reports.
Sources report BASF and Evonik are in discussions regarding a potential merger to consolidate Europe's chemical sector. Speculation drove Evonik shares up 7%, though both companies declined to comment
BASF confirmed exploratory talks to acquire German specialty chemicals firm Evonik from owner RAG-Stiftung, though outcomes remain uncertain. Evonik simultaneously pursues restructuring with plans to
Evonik and shareholder RAG-Stiftung confirmed BASF's non-binding approach for a potential takeover, aiming to strengthen BASF's specialty chemicals portfolio. The move follows market speculation and r
German chemical giant Evonik announced a strengthened growth strategy targeting Asia and Americas, restructuring portfolios toward specialty polymers and biotech while raising 2026 EBITDA guidance to
European chemical giants like Victrex and Evonik stand to gain from surging PEEK demand driven by humanoid robotics, despite facing stiff competition from rapidly expanding Chinese capacity in the pro
Evonik announced a restructuring plan cutting 3,200 jobs and divesting assets to fund growth in healthcare and biotechnology, raising its 2026 EBITDA guidance to €2.0 billion-2.2 billion. It plans to
Evonik broke ground on an €80 million biotech expansion at its Slovak Fermas site to boost pharmaceutical intermediate production via fermentation, scheduled for completion in early 2028.
Evonik announced plans to close its Hamburg and Bitterfeld production sites by 2027, citing structural inefficiencies and cost competitiveness. This move is part of a broader restructuring strategy to
Evonik announced plans to construct a new GMP-compliant LNP drug production facility in Vancouver with over 150 million CAD investment, targeting 2029 completion. The project will triple existing capa
Evonik concluded its fourth 'Growth Unlimited' vocational empowerment program, releasing a talent capability map to address digital and green transformation needs across seven cities.
Evonik will support Neptune Energy's Altmark lithium extraction project in Germany using its Liocel adsorbent technology during Pilot Phase II. The project targets industrial-scale deployment for a re
Evonik reported a 24% year-on-year increase in adjusted EBITDA to €630 million for Q2 2026, raising its full-year outlook to €2–2.2 billion. Growth stemmed from an 11% sales increase and opportunities
Major European chemical firms including BASF and Evonik reported Q2 earnings beating expectations driven by price increases, prompting raised full-year forecasts despite persistent industry production
Major chemical companies like BASF and Evonik upgraded full-year earnings projections following strong Q2 performance, though raw material cost inflation and geopolitical tensions remain significant h
The German Chemical Industry Association (VCI) downgraded its 2026 production forecast by 1.5%, citing a 3% H1 output decline and high energy costs. Major firms like BASF and Evonik are cutting jobs a
Evonik has launched its AEM anion exchange membrane pilot plant in Marl, Germany, supporting 2.5 GW electrolyzer capacity for cost-effective green hydrogen. The DURAION membranes reduce investment cos
Evonik will invest $100 million over five years to modernize its Lafayette, Indiana facility, enhancing API manufacturing capabilities and automation. This strategic move aims to meet growing US deman
ChemBrief